$LIFE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in aTYR PHARMA INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in aTYR PHARMA INC. Get notifications about new insider transactions in aTYR PHARMA INC for free.

Page:   1 2 3 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 25 2021LIFEaTYR PHARMA INCZaknoen SaraDirectorOption ExerciseA4.452,28510,1682,285
Apr 29 2021LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA4.211,4286,0121,428
Apr 29 2021LIFEaTYR PHARMA INCLucas SvetlanaDirectorOption ExerciseA4.211,4286,0121,428
Apr 29 2021LIFEaTYR PHARMA INCGross Jane ADirectorOption ExerciseA4.211,4286,0121,428
Apr 29 2021LIFEaTYR PHARMA INCCOUGHLIN TIMOTHYDirectorOption ExerciseA4.211,4286,0121,428
Apr 29 2021LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA4.211,4286,0121,428
Feb 09 2021LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseM0.0089200
Feb 09 2021LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...SellS7.663902,9879,83310.2 K to 9.8 K (-3.81 %)
Feb 09 2021LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyM0.00892010,2239.3 K to 10.2 K (+9.56 %)
Feb 09 2021LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseM0.001,78500
Feb 09 2021LIFEaTYR PHARMA INCShukla SanjayPresident and CEOSellS7.667785,9598,2989.1 K to 8.3 K (-8.57 %)
Feb 09 2021LIFEaTYR PHARMA INCShukla SanjayPresident and CEOBuyM0.001,78509,0767.3 K to 9.1 K (+24.48 %)
Feb 08 2021LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA4.52120,000542,400120,000
Feb 08 2021LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselOption ExerciseA4.5245,000203,40045,000
Feb 08 2021LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA4.5250,000226,00050,000
Sep 03 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.017,26029,113110,583117.8 K to 110.6 K (-6.16 %)
Sep 03 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.00100400117,843117.9 K to 117.8 K (-0.08 %)
Aug 28 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.095,44022,250117,943123.4 K to 117.9 K (-4.41 %)
Aug 28 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.302,2009,451123,383125.6 K to 123.4 K (-1.75 %)
Aug 28 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.095,44022,250117,943123.4 K to 117.9 K (-4.41 %)
Aug 28 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorSellS4.302,2009,451123,383125.6 K to 123.4 K (-1.75 %)
Jun 23 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyP4.221,8507,8079,1537.3 K to 9.2 K (+25.33 %)
Jun 23 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOBuyP4.276,00025,6207,2911.3 K to 7.3 K (+464.76 %)
May 28 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA4.0630,000121,80030,000
May 28 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA4.0680,000324,8000
May 28 2020LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselOption ExerciseM0.0089200
May 28 2020LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselOption ExerciseA4.0630,000121,80030,000
May 28 2020LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselSellS3.623221,1662,7353.1 K to 2.7 K (-10.53 %)
May 28 2020LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselBuyM0.0089203,0572.2 K to 3.1 K (+41.20 %)
May 22 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorSellS3.648,44730,739429,143437.6 K to 429.1 K (-1.93 %)
May 08 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCLucas SvetlanaDirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCHatfield Jeffrey S.DirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCGross Jane ADirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCCOUGHLIN TIMOTHYDirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCCOUGHLIN TIMOTHYDirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA3.651,4285,2121,428
May 08 2020LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA3.651,4285,2121,428
Feb 11 2020LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP4.25254,0001,079,500437,590183.6 K to 437.6 K (+138.35 %)
Feb 07 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseM0.001,78601,786
Feb 07 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA4.3939,327172,64639,327
Feb 07 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOSellS4.037453,0021,2912 K to 1.3 K (-36.59 %)
Feb 07 2020LIFEaTYR PHARMA INCShukla SanjayPresident and CEOBuyM0.001,78602,036250 to 2 K (+714.40 %)
Feb 07 2020LIFEaTYR PHARMA INCDENYES NANCYGeneral CounselOption ExerciseA4.3913,77860,48513,778
Feb 07 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseM0.008930893
Feb 07 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA4.3923,359102,54623,359
Feb 07 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...SellS4.033751,5117,1257.5 K to 7.1 K (-5.00 %)
Feb 07 2020LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyM0.0089307,5006.6 K to 7.5 K (+13.52 %)
Jul 02 2019LIFEaTYR PHARMA INCLucas SvetlanaDirectorOption ExerciseA5.132,28511,7212,285
May 20 2019LIFEaTYR PHARMA INCKrueger NancyGeneral CounselOption ExerciseM0.0012,500012,500
May 20 2019LIFEaTYR PHARMA INCKrueger NancyGeneral CounselSellS0.454,6512,09325,34830 K to 25.3 K (-15.50 %)
May 20 2019LIFEaTYR PHARMA INCKrueger NancyGeneral CounselBuyM0.0012,500029,99917.5 K to 30 K (+71.43 %)
May 10 2019LIFEaTYR PHARMA INCBLAIR JAMES CDirectorOption ExerciseA0.5820,00011,66820,000
May 10 2019LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA0.5820,00011,66820,000
May 10 2019LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA0.5820,00011,66820,000
May 10 2019LIFEaTYR PHARMA INCHatfield Jeffrey S.DirectorOption ExerciseA0.5820,00011,66820,000
May 10 2019LIFEaTYR PHARMA INCCoughlin Timothy PDirectorOption ExerciseA0.5820,00011,66820,000
May 10 2019LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA0.5820,00011,66820,000
Apr 16 2019LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorGrantA0.541,848,4281,000,0002,570,242721.8 K to 2.6 M (+256.08 %)
Feb 08 2019LIFEaTYR PHARMA INCKrueger NancyGeneral CounselOption ExerciseA0.52125,00064,650125,000
Feb 08 2019LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA0.0025,000025,000
Feb 08 2019LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA0.5250,00025,86050,000
Feb 08 2019LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA0.0050,000050,000
Feb 08 2019LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA0.52200,000103,440200,000
Dec 26 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorBuyP0.42195,00082,602615,382420.4 K to 615.4 K (+46.39 %)
Dec 26 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorBuyP0.4150,00020,645420,382370.4 K to 420.4 K (+13.50 %)
Nov 28 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP0.54147,22579,796882,302735.1 K to 882.3 K (+20.03 %)
Sep 21 2018LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyP0.8438,00031,73890,00052 K to 90 K (+73.08 %)
Sep 21 2018LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyP0.8126,00021,11752,00026 K to 52 K (+100.00 %)
Sep 18 2018LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...BuyP0.7326,00019,05526,0000 to 26 K
Sep 05 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP0.7620,74915,709735,077714.3 K to 735.1 K (+2.90 %)
Sep 05 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP0.7222,00015,752714,328692.3 K to 714.3 K (+3.18 %)
Aug 31 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP0.7689,27567,483692,328603.1 K to 692.3 K (+14.80 %)
Aug 31 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP0.7275,13654,090603,053527.9 K to 603.1 K (+14.23 %)
Aug 01 2018LIFEaTYR PHARMA INCBroadfoot Jill MarieChief Financial Off ...Option ExerciseA0.82200,000163,020200,000
Jun 07 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksOption ExerciseM0.003,33303,333
Jun 07 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksBuyM0.003,333026,26422.9 K to 26.3 K (+14.53 %)
May 21 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP1.00150,000149,445527,917377.9 K to 527.9 K (+39.69 %)
May 17 2018LIFEaTYR PHARMA INCBLAIR JAMES CDirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCNashat AmirDirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCHatfield Jeffrey S.DirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCCoughlin Timothy PDirectorOption ExerciseA1.3520,00027,00020,000
May 17 2018LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA1.3520,00027,00020,000
May 16 2018LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS0.812,733,2312,216,92402.7 M to 0 (-100.00 %)
May 16 2018LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS1.43121,294173,0622,733,2312.9 M to 2.7 M (-4.25 %)
May 16 2018LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS1.72354,791609,0702,854,5253.2 M to 2.9 M (-11.06 %)
Feb 08 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksOption ExerciseM0.003,33406,666
Feb 08 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksOption ExerciseA3.30100,000330,000100,000
Feb 08 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksSellS3.401,4024,7671,9323.3 K to 1.9 K (-42.05 %)
Feb 08 2018LIFEaTYR PHARMA INCAmanullah AshrafSee RemarksBuyM0.003,33403,3340 to 3.3 K
Feb 08 2018LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA3.30300,000990,000300,000
Feb 08 2018LIFEaTYR PHARMA INCKing David JohnChief Scientific Of ...Option ExerciseA3.30150,000495,000150,000
Feb 08 2018LIFEaTYR PHARMA INCBlake John TSenior Vice Preside ...Option ExerciseM0.003,33406,666
Feb 08 2018LIFEaTYR PHARMA INCBlake John TSenior Vice Preside ...Option ExerciseA3.3075,000247,50075,000
Feb 08 2018LIFEaTYR PHARMA INCBlake John TSenior Vice Preside ...SellS3.401,4024,7671,9323.3 K to 1.9 K (-42.05 %)
Feb 08 2018LIFEaTYR PHARMA INCBlake John TSenior Vice Preside ...BuyM0.003,33403,3340 to 3.3 K
Jan 02 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA3.8032,000121,60032,000
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS3.951,0834,2783,209,3163.2 M to 3.2 M (-0.03 %)
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS4.005,86023,4453,210,3993.2 M to 3.2 M (-0.18 %)
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS4.155,81924,1513,216,2593.2 M to 3.2 M (-0.18 %)
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerSellS4.301,0704,6013,222,0783.2 M to 3.2 M (-0.03 %)
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerBuyP4.8024,728118,6943,223,1483.2 M to 3.2 M (+0.77 %)
Dec 14 2017LIFEaTYR PHARMA INCEcoR1 Capital Fund Qualified, ...10% OwnerBuyP5.054,87924,6393,198,4203.2 M to 3.2 M (+0.15 %)
Nov 03 2017LIFEaTYR PHARMA INCShukla SanjayPresident and CEOOption ExerciseA4.00450,0001,800,000450,000
Sep 05 2017LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseP4.6435,376164,14535,376
Sep 05 2017LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP2.6594,336249,990377,917283.6 K to 377.9 K (+33.27 %)
Sep 05 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorOption ExerciseP4.6414,15165,66114,151
Sep 05 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP2.6537,736100,000367,883330.1 K to 367.9 K (+11.43 %)
May 11 2017LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCNashat AmirDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCHatfield Jeffrey S.DirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCGoldberg Mark AlanDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCCoughlin Timothy PDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCAKKARAJU SRINIVASDirectorOption ExerciseA3.1520,00063,00020,000
May 11 2017LIFEaTYR PHARMA INCBLAIR JAMES CDirectorOption ExerciseA3.1520,00063,00020,000
Apr 26 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.00124372327,647327.5 K to 327.6 K (+0.04 %)
Apr 20 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.001,5524,656327,523326 K to 327.5 K (+0.48 %)
Apr 20 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.001,0003,000325,971325 K to 326 K (+0.31 %)
Apr 10 2017LIFEaTYR PHARMA INCCoughlin Timothy PDirectorOption ExerciseA3.2532,000104,00032,000
Feb 09 2017LIFEaTYR PHARMA INCShukla SanjayChief Medical Offic ...Option ExerciseA3.3065,000214,50065,000
Feb 09 2017LIFEaTYR PHARMA INCRavindran Sanuj K.Chief Business Offi ...Option ExerciseA3.3040,000132,00040,000
Feb 09 2017LIFEaTYR PHARMA INCMatsuoka GroveSee RemarksOption ExerciseA3.3020,00066,00020,000
Feb 09 2017LIFEaTYR PHARMA INCKing David JohnSee RemarksOption ExerciseA3.3065,000214,50065,000
Feb 09 2017LIFEaTYR PHARMA INCAmanullah AshrafVice President, Man ...Option ExerciseA0.0010,000010,000
Feb 09 2017LIFEaTYR PHARMA INCAmanullah AshrafVice President, Man ...Option ExerciseA3.3035,000115,50035,000
Dec 22 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP2.2810,00022,818721,814711.8 K to 721.8 K (+1.40 %)
Dec 22 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP2.2715,00034,110711,814696.8 K to 711.8 K (+2.15 %)
Dec 21 2016LIFEaTYR PHARMA INCAmanullah AshrafVice President, Man ...BuyP2.2511,00024,74911,0000 to 11 K
Dec 21 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP2.2069,000151,662324,971256 K to 325 K (+26.96 %)
Dec 19 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP2.4010,00023,973696,814686.8 K to 696.8 K (+1.46 %)
Dec 19 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorBuyP2.5040,00099,912686,814646.8 K to 686.8 K (+6.18 %)
Dec 19 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorGiftG0.0012,5720646,814634.2 K to 646.8 K (+1.98 %)
Dec 19 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorGiftG0.0012,572040,44053 K to 40.4 K (-23.72 %)
Sep 22 2016LIFEaTYR PHARMA INCKing David JohnSee RemarksOption ExerciseA3.29145,000477,050145,000
Sep 15 2016LIFEaTYR PHARMA INCCubitt AndrewVP, Product Protect ...Option ExerciseA3.0625,00076,50025,000
Sep 15 2016LIFEaTYR PHARMA INCRavindran Sanuj K.Chief Business Offi ...Option ExerciseA3.0645,500139,23045,500
Sep 15 2016LIFEaTYR PHARMA INCAmanullah AshrafVice President, Man ...Option ExerciseA3.0628,00085,68028,000
Sep 15 2016LIFEaTYR PHARMA INCShukla SanjayChief Medical Offic ...Option ExerciseA3.0627,50084,15027,500
Sep 15 2016LIFEaTYR PHARMA INCMatsuoka GroveSee RemarksOption ExerciseA3.0620,00061,20020,000
Sep 15 2016LIFEaTYR PHARMA INCBlake John TVice President, Fin ...Option ExerciseA3.0619,00058,14019,000
May 26 2016LIFEaTYR PHARMA INCBLAIR JAMES CDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCSCHIMMEL PAULDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCNashat AmirDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCGoldberg Mark AlanDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCFALBERG KATHRYN EDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCCLARKE JOHN KDirectorOption ExerciseA3.3318,00059,94018,000
May 26 2016LIFEaTYR PHARMA INCAKKARAJU SRINIVASDirectorOption ExerciseA3.3318,00059,94018,000

Page:   1 2 3 next >

Contact us | Follow us on Twitter